Nippon Shinyaku Co., Ltd. (NPNKF)

Market Cap	1.49B
Revenue (ttm)	1.11B
Net Income (ttm)	211.74M
Shares Out	n/a
EPS (ttm)	3.14
PE Ratio	7.04
Forward PE	n/a
Dividend	0.83 (3.26%)
Ex-Dividend Date	Sep 29, 2025

Volume	90
Average Volume	n/a
Open	41.82
Previous Close	25.58
Day's Range	25.58 - 41.82
52-Week Range	23.58 - 41.82
Beta	-0.28
RSI	39.35
Earnings Date	Aug 7, 2025

About Nippon Shinyaku

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leb...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1911
• Employees: 2,243
• Stock Exchange: OTCMKTS
• Ticker Symbol: NPNKF

Financial Performance

In 2024, Nippon Shinyaku's revenue was 160.23 billion, an increase of 8.08% compared to the previous year's 148.26 billion. Earnings were 32.56 billion, an increase of 25.94%.

Financial numbers in JPY